Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Huntington Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Huntington Disease (diet therapy) < Huntington Disease (drug therapy) < Huntington Disease (enzymology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 40.
[20-40] [0 - 20][0 - 40][40-39][40-60]
Ident.Authors (with country if any)Title
002D55 (2010) H Christopher Hyson ; Karl Kieburtz ; Ira Shoulson ; Michael Mcdermott ; Bernard Ravina ; Elisabeth A. De Blieck ; Merit E. Cudkowicz ; Robert J. Ferrante ; Peter Como ; Sam Frank ; Carol Zimmerman ; Merit E. Cudkowicz ; Kimberly Ferrante ; Kristyn Newhall ; Danna Jennings ; Tammie Kelsey ; Francis Walker ; Vicki Hunt ; Susan Daigneault ; Michele Goldstein ; Joseph Weber ; Arthur Watts ; M Flint Beal ; Susan E. Browne ; Linda J. MetakisSafety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.
002D93 (2010) A futility study of minocycline in Huntington's disease.
003064 (1990) C G Goety ; C M Tanner ; J A Cohen ; J A Thelen ; V S Carroll ; H L Klawans ; R G FarielloL-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
003429 (2012) Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl KieburtzPharmacologic approaches to the treatment of Huntington's disease.
003881 (2012) Leslie J. Cloud [États-Unis] ; Adam Rosenblatt ; Russel L. Margolis ; Christopher A. Ross ; Jagan A. Pillai ; Jody Corey-Bloom ; Hannah M. Tully ; Thomas Bird ; Peter K. Panegyres ; Charles A. Nichter ; Donald S. Higgins ; Sandra L. Helmers ; Stewart A. Factor ; Randi Jones ; Claudia M. TestaSeizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.
003958 (2013) Raja Mehanna [États-Unis] ; Christine Hunter ; Anthony Davidson ; Joohi Jimenez-Shahed ; Joseph Jankovic [États-Unis]Analysis of CYP2D6 genotype and response to tetrabenazine.
003A72 (2013) A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.
003B69 (2013) Ralf Reilmann [Allemagne]Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
003C37 (2013) Ralf Reilmann [Allemagne]The pridopidine paradox in Huntington's disease.
003E74 (2013) Leigh J. Beglinger [États-Unis] ; William H. Adams [États-Unis] ; Douglas Langbehn [États-Unis] ; Jess G. Fiedorowicz [États-Unis] ; Ricardo Jorge [États-Unis] ; Kevin Biglan [États-Unis] ; John Caviness [États-Unis] ; Blair Olson [États-Unis] ; Robert G. Robinson [États-Unis] ; Karl Kieburtz [États-Unis] ; Jane S. Paulsen [États-Unis]Results of the Citalopram to Enhance Cognition in Huntington Disease Trial
004021 (2014) S. Tunc ; P. Capetian ; Alexander MünchauHope for Huntington's disease? A novel approach for disease modification.
004174 (2015) Raymond Y. Lo [Taïwan] ; Karla P. Figueroa ; Stefan M. Pulst ; Chi-Ying Lin ; Susan Perlman ; George Wilmot ; Christopher Gomez ; Jeremy Schmahmann ; Henry Paulson ; Vikram G. Shakkottai ; Sarah Ying ; Theresa Zesiewicz ; Khalaf Bushara ; Michael Geschwind ; Guangbin Xia ; S H Subramony ; Tetsuo Ashizawa ; Sheng-Han KuoCoenzyme Q10 and spinocerebellar ataxias.
004176 (2015) Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe VernyA phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
004857 (1994) S S Rich [États-Unis] ; F. OvsiewLeuprolide acetate for exhibitionism in Huntington's disease.
004A96 (1996) K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J T Greenamyre ; C. Dunn ; I. ShoulsonA controlled trial of remacemide hydrochloride in Huntington's disease.
004B03 (1996) A. Feigin [États-Unis] ; K. Kieburtz ; P. Como ; C. Hickey ; K. Claude ; D. Abwender ; C. Zimmerman ; K. Steinberg ; I. ShoulsonAssessment of coenzyme Q10 tolerability in Huntington's disease.
004B50 (1996) M. Ossemann ; C J Sindic ; C. LaterreTetrabenazine as a cause of neuroleptic malignant syndrome.
004B68 (1996) J P Van Vugt [Pays-Bas] ; B J Van Hilten ; R A RoosHypokinesia in Huntington's disease.
004B99 (1996) N G Ranen [États-Unis] ; C E Peyser ; J T Coyle ; F W Bylsma ; M. Sherr ; L. Day ; M F Folstein ; J. Brandt ; C A Ross ; S E FolsteinA controlled trial of idebenone in Huntington's disease.
004D36 (1997) S A Factor [États-Unis] ; J H FriedmanThe emerging role of clozapine in the treatment of movement disorders.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Huntington Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Huntington Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Huntington Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024